skip to main content

Apixaban adherence — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsApixaban adherenceGPhC CRA

An older woman with AF and previous TIA forgets evening apixaban doses and asks for a monitored dosage system. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Assess adherence support and involve the prescriber if needed

This scenario assesses Apixaban adherence in a UK pharmacy practice context. Missed DOAC doses quickly reduce anticoagulant protection, so adherence barriers need active management. The best answer is Assess adherence support and involve the prescriber if needed because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: GPhC Standards; BNF